MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-02-0047368
Tosco Pharma Private Limited
Tosco Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹20.42 Cr
▲ 337% YoY
Net loss · FY 2024
₹3.27 Cr
Net margin -16%
EBITDA · FY 2024
₹28.92 Lakh
EBITDA margin 1.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹13 Cr
Satisfied ₹11 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
25
Provident fund records
About Tosco Pharma Private Limited
Data last updated:
Tosco Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Tosco Pharmachem Privat. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 31 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC092639. Its GSTIN is 37AAUCS1839C1Z2 (Andhra Pradesh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Snehaa Pharmachem Private Limited. It is led by directors including Srinivasa Raju Kanumuri and Venkata Suryanarayana Raju Sagi.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 28/1 First Floor Balanagar Technocrat Industrial Estate, Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.42 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.27 Cr (net margin -16%) and EBITDA of ₹28.92 Lakh (EBITDA margin 1.4%).
The company has about 25 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹13 Cr and satisfied charges of ₹11 Cr on record. The company has 3 deals on record (1 secondary share transfer, 1 funding round, 1 rights issue), with disclosed funding of ₹2.29 Cr; the latest was in March 2018. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Anphar Laboratories Private Limited with revenue of ₹20.75 Cr.
Tosco Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0047368). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Tosco Pharma Private Limited
CIN U24232TG2014PTC092639
Registration Number 092639
Incorporation Date 31 January 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Tosco Pharmachem Privat
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-02-0047368
CIN History of Tosco Pharma Private Limited
Tosco Pharma has one previous CIN (Corporate Identification Number): U24232AP2014PTC092639. The current CIN is U24232TG2014PTC092639, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2014PTC092639 | Current |
| U24232AP2014PTC092639 | Previous |
Key People
Srinivasa Raju Kanumuri Director Venkata Suryanarayana Raju Sagi Director Venkata Subrahmanya Janaki Rama Varma Sagi Additional Director Recognitions & Rankings of Tosco Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 28/1 First Floor Balanagar Technocrat Industrial Estate, Hyderabad, Telangana, India – 500037
- IndustryPharma, API Manufacturers
Comprehensive company report
Tosco Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Tosco Pharma Private Limited
The main business activity of Tosco Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Tosco Pharma Private Limited FY 2025 filings available
Tosco Pharma Private Limited reported revenue of ₹20.42 Cr (up 337% YoY) for FY 2024.
Revenue · FY 2024
₹20.42 Cr ▲ 337%
Net loss · FY 2024
₹3.27 Cr margin -16%
EBITDA · FY 2024
₹28.92 Lakh margin 1.4%
Compounded Annual Growth Rate (CAGR) of Tosco Pharma Private Limited
Revenue CAGR growth
1 year
▲ 337%
EBITDA CAGR growth
1 year
▼ 77%
5 years · compounded
▲ 34%
Revenue rose 337% in the latest year. EBITDA fell 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Tosco Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹28.92 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.27 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Tosco Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -16% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tosco Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Tosco Pharma Private Limited
Tosco Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Raju Kanumuri Also directs: Hawai Aqua India Private Limited, GMFC Labs Private Limited, GMFC Pharma Private Limited and 3 more | Director | 01 Feb 2021 | 5 Years 8 Months | Current |
| Venkata Suryanarayana Raju Sagi | Director | 04 Nov 2021 | 4 Years 11 Months | Current |
| Venkata Subrahmanya Janaki Rama Varma Sagi | Additional Director | 04 Dec 2025 | 0 Years 10 Months | Current |
Peer Comparison of Tosco Pharma Private Limited
Tosco Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anphar Laboratories Private Limited | ₹20.75 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Jammu, Jammu and Kashmir, India |
| SBD Healthcare Private Limited | ₹20.74 Cr (FY 2024) | •••• | •••• | 92.0% | •••• | Ankleshwar, Gujarat, India |
| Medinex Laboratories Private Limited | ₹20.62 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Bhavnagar, Gujarat, India |
| Reflux Pharmaceuticals Private Limited | ₹20.56 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Thane, Maharashtra, India |
| Altis Finechem Private Limited | ₹20.53 Cr (FY 2025) | •••• | •••• | 62.0% | •••• | Prantij, Gujarat, India |
| Tosco Pharma Private Limited this company | ₹20.42 Cr (FY 2024) | •••• | •••• | 337.0% | •••• | Hyderabad, Telangana, India |
| Tesla Chemicals Private Limited | ₹20.24 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Panoli, Gujarat, India |
| Pharchem Private Limited | ₹20.2 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Boisar, Maharashtra, India |
| Suyog Life Sciences Private Limited | ₹20.09 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ankleshwar, Gujarat, India |
| Frinze Laboratories Private Limited | ₹20.07 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Auro Laboratories Limited Listed | ₹20.05 Cr (FY 2025) | •••• | •••• | -64.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Tosco Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Tosco Pharma Private Limited
Tosco Pharma Private Limited is audited by DATLA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DATLA & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Tosco Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tosco Pharma Private Limited
Open charges
₹13 Cr
Satisfied charges
₹11 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2023 | Hdfc Bank Limited | ₹13 Cr | Open |
| 24 Dec 2021 | Others | ₹5 Cr | Satisfied |
| 24 Dec 2021 | Others | ₹6 Cr | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Tosco Pharma Private Limited
Tosco Pharma Private Limited has 3 deals on record (1 secondary share transfer, 1 funding round, 1 rights issue), with disclosed funding of ₹2.29 Cr; the latest was in March 2018.
Total deals
3
Secondary share transfer
1
Funding round
1
Rights issue
1
Disclosed funding
₹2.29 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: Lakshmi Saras Chemtech Private Limited , 2 individuals Seller: Others, 3 individuals |
| Feb 2017 | Rights issue | ₹50 Lakh | Investors: 4 individuals |
| Mar 2015 | Funding round | ₹2.29 Cr | Investors: 4 individuals |
Premium access
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Tosco Pharma Private Limited
Tosco Pharma Private Limited has a workforce of 25 employees as of Apr 09, 2024.
Employee count
25
Active EPFO establishments
1
Employee growth
31.58%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Tosco Pharma Private Limited
Tosco Pharma Private Limited has 10 board changes on record since 2015: 3 appointments and 7 cessations. The latest: Venkata Suryanarayana Raju Sagi ceased to be Director on 06 Dec 2025.
Ceased
Venkata Suryanarayana Raju Sagi ceased to be Director.
Appointed
Venkata Subrahmanya Janaki Rama Varma Sagi was appointed as Additional Director.
AGM
Tosco Pharma Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records.
Filing
Tosco Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 13.00 Cr registered on 01 Aug 2023 with Charge ID 100801174 was modified on 04 Mar 2024.
Charges
A charge registered on 24 Dec 2021 via Charge ID 100550664 with Others was fully satisfied on 17 Oct 2023.
Charges
A charge registered on 24 Dec 2021 via Charge ID 100550669 with Others was fully satisfied on 17 Oct 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.00 Cr with Charge ID 100801174 was registered on 01 Aug 2023.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100550664 was registered on 24 Dec 2021.
Charges
A charge with Others amounted to Rs. 6.00 Cr with Charge ID 100550669 was registered on 24 Dec 2021.
Ceased
Bhaskara Raju Reddycherla ceased to be Additional Director.
Appointed
Venkata Suryanarayana Raju Sagi was appointed as Director.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Tosco Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tosco Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tosco Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Tosco Pharma Private Limited
Tosco Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAUCS1839C1Z2 | Andhra Pradesh | Active | 09 Nov 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tosco Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tosco Pharma Private Limited
Tosco Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 31 January 2014 (12+ years old) and is registered under CIN U24232TG2014PTC092639.
Tosco Pharma reported revenue of ₹20.42 Cr for FY 2024 (up 337% YoY).
Tosco Pharma has 3 current directors:
- Srinivasa Raju Kanumuri - Director
- Venkata Suryanarayana Raju Sagi - Director
- Venkata Subrahmanya Janaki Rama Varma Sagi - Additional Director
Tosco Pharma reported a net loss of ₹3.27 Cr (net margin -16%) and EBITDA of ₹28.92 Lakh (EBITDA margin 1.4%) for FY 2024, as per its filed financial statements.
The GSTIN of Tosco Pharma is 37AAUCS1839C1Z2, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Tosco Pharma is U24232TG2014PTC092639. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tosco Pharma was incorporated on 31 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Tosco Pharma has 3 deals on record (1 secondary share transfer, 1 funding round, 1 rights issue), with disclosed funding of ₹2.29 Cr; the latest was in March 2018.
The peers of Tosco Pharma by revenue are Anphar Laboratories Private Limited, SBD Healthcare Private Limited, Medinex Laboratories Private Limited, Reflux Pharmaceuticals Private Limited, Altis Finechem Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Venkata Suryanarayana Raju Sagi ceased to be Director on 06 Dec 2025. Venkata Subrahmanya Janaki Rama Varma Sagi was appointed as Additional Director on 04 Dec 2025. Bhaskara Raju Reddycherla ceased to be Additional Director on 06 Nov 2021. Tosco Pharma has 10 board changes on record in total.
Yes, Tosco Pharma is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0047368).